| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:e95.)
© 2003 American Heart Association, Inc.
Research Reports |
From the School of Surgery and Pathology, University of Western Australia, Fremantle Hospital, Fremantle (P.E.N.); Centre for Health Services Research, Western Australian Safety and Quality of Surgical Care Project, School of Population Health, University of Western Australia, Nedlands (J.B.S., C.L.L.); and Mount Medical Centre, Perth (M.L.-B.), Western Australia.
Correspondence to Associate Professor Paul Norman, School of Surgery and Pathology, University of Western Australia, Fremantle Hospital, PO Box 480, Fremantle, Western Australia 6959. E-mail pnorman{at}cyllene.uwa.edu.au
| Abstract |
|---|
|
|
|---|
80 years of age undergoing carotid endarterectomy. Methods A population-based record linkage study of all patients who underwent carotid endarterectomy from 1988 to 1998 in Western Australia was undertaken. Long-term relative survival after carotid endarterectomy was assessed against age- and sex-matched controls.
Results During the period 1988 to 1998, 1796 (1306 male, 490 female) cases were identified. There were 151 patients
BORDER="0">80 years of age. The cumulative survival at 5 years was 64.9% for those
80 years of age compared with 80.1% for those <80 years of age. Relative survival at 5 years was 118% (95% CI, 102 to 134) for those
80 years of age compared with 94.7% (95% CI, 92 to 97) for those <80 years of age.
Conclusions Long-term relative survival after carotid endarterectomy in patients
80 years of age was better than that of an age-matched population. The likelihood of living long enough to gain benefit from a carotid endarterectomy is not jeopardized by being too old.
Key Words: carotid endarterectomy octogenarian survival
| Introduction |
|---|
|
|
|---|
One increasingly important group of patients excluded from the major trials are those
80 years of age.3 Recent reanalysis of outcome in these trials based on age showed that patients
75 years of age obtained more benefit from CEA than younger patients.4,5 The reason is that older patients have the highest risk of ischemic stroke if treated medically and the lowest surgical risk.5 Whether this finding also applies to patients
80 years of age cannot be readily answered from the trial data.
There are reports that the elderly, including octogenarians, can undergo CEA safely.6 Despite cogent arguments3 that most octogenarians would probably live long enough to benefit from CEA, there are few studies of long-term survival in the very elderly after CEA. The present study used data from the Western Australia Data Linkage System to measure the long-term survival of patients undergoing CEA to assess relative survival in the very elderly.
| Patients and Methods |
|---|
|
|
|---|
Relative survival is the ratio of the survival observed in patients to the survival of a population that matched by calendar period, geographical location, age, and sex. Relative survival analysis was performed with a SAS macro based on the Hakulinen method.9 The computer program was modified to include annual life table data for the Western Australian population in 1980 to 1998 supplied by the Australian Bureau of Statistics. Differences in relative survival by sex and octogenarian age group were evaluated by 95% CIs. Other differences between patients <80 and
80 years of age were determined by the
2 and Wilcoxon tests. Cox proportional-hazards regression evaluated the effect of sex on the risk of dying, adjusting for age.
| Results |
|---|
|
|
|---|
There were 101 men (8%) and 50 women (10%)
80 years of age. The proportion of octogenarians increased steadily from 1.5% in 1988 to 1990 to 12.4% in 1997 to 1998. Differences between patients
80 and <80 years are summarized in the Table. The cumulative survival at 5 years for octogenarians and for those <80 years of age is shown in Figure 1 (log rank test,
2=16.34, P<0.0001); relative survival is shown in Figure 2.
|
|
|
| Discussion |
|---|
|
|
|---|
80 years of age. Because octogenarians were not included in the major trials of CEA, clinicians have had to base their management of increasing numbers of elderly patients on data from additional sources. Reports from single institutions indicate that CEA can be performed in octogenarians with acceptable 30-day stroke and mortality rates.6 Although most studies show that both stroke and death within 30 days of CEA tend to be higher in octogenarians compared with those <80 years of age, the difference is not usually considered clinically significant. Outcomes within 30 days in the present study are comparable to similar population-based series,11 with a combined death and stroke incidence of 2.6% in octogenarians. This is almost certainly an underestimation because patients were not reviewed independently by a neurologist.
Despite evidence that the incidence of stroke increases with age, 12 outcome from medical treatment is worse in the elderly,5 and early surgical outcome is reasonable in octogenarians, clinicians still have doubts about the overall benefit of CEA in these patients. This concern is due in part to uncertainty about the life expectancy of elderly patients with significant atherosclerotic disease. Previous economic analyses of CEA suggested that on the basis of poor long-term survival, the procedure was unlikely to be cost-effective in patients >79 years of age.13 There are a small number of single-institution reports of long-term survival in octogenarians after CEA; the study from the Cleveland Clinic6 is the only one of sufficient size (n=167) and duration to report a meaningful cumulative 5-year survival of 45% (42% stroke free) in octogenarians.
The cumulative 5-year survival for octogenarians in our study was 64.9% (Figure 1). However, when background all-cause mortality is taken into account, relative survival was greater (118.0%) in octogenarians after CEA than that of a matched population (Figure 2). Obviously, the patients undergoing CEA, particularly those in their 80s, were carefully selected, but the data show that those that have been selected have greater longevity than the average octogenarian.
The focus of this study has been on overall survival. Clearly, stroke-free survival and quality of life are also important issues. The feasibility of studying late nonfatal stroke using the Western Australia Data Linkage System is limited by the facts that at least 20% of stroke cases are not admitted to hospital and that the system does not contain data from community-based general practices.12 As can be seen from the Table, the proportion of late deaths attributed to ischemic stroke in octogenarians (4.4%) was less than in those
80 years of age (9.4%). Although it is possible that there were a greater number of nonfatal strokes in the older age group, there is no reason to suspect that the overall (fatal and nonfatal) incidence of stroke was greater.
Clinical decisions about performing CEA in the very elderly are difficult, particularly in the absence of trial data. Although no one wants to have an operation, uncomplicated CEA is not a major procedure in terms of postoperative pain, length of hospital stay, complexity of follow-up, and length of convalescence. These are increasingly important considerations as a patients age increases. In this study, perioperative morbidity and mortality were not increased in older patients, and the likelihood of living long enough to gain benefit from CEA was not jeopardized by being too old.
| Acknowledgments |
|---|
Received October 29, 2002; revision received January 27, 2003; accepted February 27, 2003.
| References |
|---|
|
|
|---|
2. European Carotid Surgery Trialists Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial. Lancet. 1998; 351: 13791387.[CrossRef][Medline] [Order article via Infotrieve]
3. Rothwell P. Carotid endarterectomy and prevention of stroke in the very elderly. Lancet. 2001; 357: 11421143.[CrossRef][Medline] [Order article via Infotrieve]
4. Rothwell P, Mayberg M, Warlow C, Barnett H. Meta-analysis of individual patients data from randomised controlled trials of carotid endarterectomy for symptomatic stenosis, 3: the efficacy of surgery in important pre-defined sub-groups. Cerebrovasc Dis. 2000; 10 (suppl 2): 108.Abstract.
5. Alamowitch S, Eliasziw M, Algra A, Meldrum H, Barnet H. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal carotid-artery stenosis. Lancet. 2001; 357: 11541160.[CrossRef][Medline] [Order article via Infotrieve]
6. OHara P, Hertzer N, Mascha E, Beven E, Krajewski L, Sullivan T. Carotid endarterectomy in octogenarians: early results and late outcome. J Vasc Surg. 1998; 27: 860871.[CrossRef][Medline] [Order article via Infotrieve]
7. Holman C, Bass A, Rouse I, Hobbs M. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999; 23: 453459.[Medline] [Order article via Infotrieve]
8. World Health Organization. ICD-9-CM: Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death: Clinical Modifications. Geneva, Switzerland: WHO; 1986.
9. Therneau T, Sicks J, Bergstralh E, Offord J. Expected Survival Based on Hazard Rates. Rochester, Minn: Mayo Clinic; 1994.Report No 52.
10. Rothwell P, Warlow C. Is self-audit reliable? Lancet. 1995; 346: 1623.[CrossRef][Medline] [Order article via Infotrieve]
11. Wennberg D, Lucas F, Birkmeyer J, Bredenberg C, Fisher E. Variation in carotid endarterectomy mortality in the medicare population. JAMA. 1998; 279: 12781281.
12. Hankey G, Jamrozik K, Broadhurst R, Forbes S, Burvill P, Anderson C, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke. 1998; 29: 24912500.
13. Cronenwett J, Birkmeyer J, Nackman G, Fillinger M, Bech F, Zwolak R, et al. Cost-effectiveness of carotid endarterectomy in asymptomatic patients. J Vasc Surg. 1997; 25: 298311.[CrossRef][Medline] [Order article via Infotrieve]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |